scholarly journals Effects of Leukocytic Pyrogen (Interleukin-1) on Local Cerebral Glucose Utilization in Rats with and without Premedication with Indomethacin or Dexamethasone

1988 ◽  
Vol 8 (2) ◽  
pp. 173-178 ◽  
Author(s):  
Floyd R. Domer ◽  
Kentaro Mori ◽  
Charles A. Dinarello ◽  
Louis Sokoloff

Changes in body temperature were recorded in freely moving rats given phosphate-buffered saline or leukocytic pyrogen (interleukin-1) while the animals were in an infant incubator maintained at 25.5 ± 0.5°C. The leukocytic pyrogen increased body temperature by at least 1°C within 1 h. This rise in temperature was prevented by premedication with indomethacin (10 mg/kg) but not dexamethasone (0.5 mg/kg) given 15 min before the leukocytic pyrogen. Local rates of glucose utilization were measured in 47 regions of the central nervous system. In none of the regions previously reported to have an increased rate of glucose utilization associated with an ambient temperature of 32.5°C (McCulloch et al., 1982b) was an increase found in the present experiments. It was concluded that the intensity of the changes in local cerebral glucose utilization in response to the fever caused by the leukocytic pyrogen was insufficient to be measured. Neither indomethacin nor dexamethasone caused remarkable changes in rates of local glucose utilization.

1982 ◽  
Vol 243 (3) ◽  
pp. H416-H423 ◽  
Author(s):  
J. McCulloch ◽  
P. A. Kelly ◽  
J. J. Grome ◽  
J. D. Pickard

The effects of indomethacin, a prostaglandin synthesis inhibitor, upon local cerebral glucose utilization and local cerebral blood flow have been examined in 36 conscious, lightly restrained rats. Cerebral glucose utilization and cerebral blood flow were determined by means of the quantitative autoradiographic techniques that utilize, respectively, 2-deoxy-D-[1-14C]glucose and iodo[14C]antipyrine as tracer molecules. The administration of indomethacin (0.3-30 mg/kg iv) did not alter significantly the rate of glucose utilization in any of the 38 discrete regions of the central nervous system that were examined. In contrast, cerebral blood flow in every region was significantly reduced by between 30 and 50% from vehicle-injected control levels after the administration of 10 mg/kg iv indomethacin and by 5-31% after 1 mg/kg iv indomethacin. These results provide further evidence that prostaglandins may play a major role in cerebrovascular regulation, but they provide no positive evidence for a role in neuronal activity, as reflected in local cerebral glucose utilization.


1991 ◽  
Vol 205 (3) ◽  
pp. 233-240 ◽  
Author(s):  
Peter Room ◽  
Antoon J.P.C. Tielemans ◽  
Thijs De Boer ◽  
Anton M.L. Van Delft ◽  
Jeroen A.D.M. Tonnaer

Peptides ◽  
2000 ◽  
Vol 21 (11) ◽  
pp. 1751-1753 ◽  
Author(s):  
Francesco E Pontieri ◽  
Maurizia Rasura ◽  
Alessandra Scontrini ◽  
Francesca R Buttarelli

Sign in / Sign up

Export Citation Format

Share Document